ANGEL PLACIDO
LLANEZA COTO
Catedrático de Universidad
Publications (62) Publications de ANGEL PLACIDO LLANEZA COTO
2024
-
Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis
Menopause (New York, N.Y.), Vol. 31, Núm. 3, pp. 234-242
-
Rural residence and health-related quality of life in a sample of Spain perimenopausal women
Gynecological Endocrinology, Vol. 40, Núm. 1
2023
-
Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review
Journal of Clinical Medicine, Vol. 12, Núm. 16
-
Population-based survey on menopausal symptoms and treatment use
Climacteric, Vol. 26, Núm. 1, pp. 47-54
2022
-
Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group
Maturitas, Vol. 166, pp. 65-85
-
Resilience, Perceived Stress, and Depressed Mood in Women Under in Vitro Fertilization Treatment
Reproductive Sciences, Vol. 29, Núm. 3, pp. 816-822
2021
-
Health-related quality of life and resilience in peri- and postmenopausal women during Covid-19 confinement
Maturitas, Vol. 144, pp. 4-10
-
Nulla dies sine linea (2014-2018)
Historia de la AEEM: 30 aniversario : 1991-2021 (Editorial Universidad de Granada), pp. 151-164
-
Predictive and criterion validity of the Cervantes-SF menopause quality of life questionnaire
Menopause (New York, N.Y.), Vol. 28, Núm. 8, pp. 935-942
-
Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study
BMC Women's Health, Vol. 21, Núm. 1
2020
-
Arterial palmar arch occlusion in a woman with Raynaud's disease taking oral combined menopausal hormone therapy: A case report
Case Reports in Women's Health, Vol. 27
-
Beliefs, knowledge and the impact of COVID19 on menopause therapies in Spanish women: COMEM-treatment study
BMC Women's Health, Vol. 20, Núm. 1
-
Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia
Maturitas, Vol. 137, pp. 57-62
-
Response to “Should estrogen be used in the co-treatment of COVID-19 patients?”
Maturitas
-
The thromboembolic risk in covid-19 women under hormonal treatment group
Maturitas
2019
-
Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial
Gynecological Endocrinology, Vol. 35, Núm. 8, pp. 695-700
-
Early fetal ultrasound screening for major congenital heart defects without Doppler
European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 233, pp. 93-97
-
Impact Of Vulvovaginal Atrophy Of Menopause In Spanish Women: Prevalence And Symptoms According To The EVES Study
Sexual Medicine, Vol. 7, Núm. 2, pp. 207-216
2018
-
"Hablemos de otra forma" acerca de la terapia hormonal en la menopausia
Progresos de Obstetricia y Ginecologia, Vol. 61, Núm. 3, pp. 221-226
-
Aeem-sego position statement on menopausal hormone therapy
Progresos de Obstetricia y Ginecologia, Vol. 61, Núm. 3, pp. 230-234